挪威儿童轮状病毒疫苗接种成本效益及效果再评估

数据集获取（Figshare）

• 源站标题：Re–evaluation of the cost–effectiveness and effects of childhood rotavirus vaccination in Norway
• DOI：10.1371/journal.pone.0183306
• 发布日期：2017-08-17
• 文件数：4 个
• 文件总体积：648.01 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Re_evaluation_of_the_cost_effectiveness_and_effects_of_childhood_rotavirus_vaccination_in_Norway/5321155

命令行下载

curl -L -o "S1 Fig.tif" "https://ndownloader.figshare.com/files/9136690"
curl -L -o "S2 Fig.tif" "https://ndownloader.figshare.com/files/9136699"
curl -L -o "S3 Fig.tif" "https://ndownloader.figshare.com/files/9136708"
curl -L -o "S1 Table.docx" "https://ndownloader.figshare.com/files/9136714"

文件清单

• S1 Fig.tif（98.09 KB）
• S2 Fig.tif（43.55 KB）
• S3 Fig.tif（491.66 KB）
• S1 Table.docx（14.71 KB）

文件总体积 648.01 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
Rotavirus vaccination was included into the Norwegian childhood immunisation programme in 2014. Before implementation, rotavirus vaccination was found to be cost–effective from a societal perspective, but not from a healthcare perspective. Since introduction, new data on the incidence and economic effects of rotavirus disease have become available. We assessed early epidemiological effects of the rotavirus vaccination programme and re–evaluated its cost–effectiveness in Norway for the years 2015–2019.
Methods
Using a dynamic transmission model, we compared the epidemiological effects of the ongoing two–dose vaccination programme with Rotarix®, and a hypothetical 3–dose programme with RotaTeq® with no vaccination. A baseline cost of € 54 per fully vaccinated child was used. Cost–effectiveness was computed from a healthcare and societal perspective, using a decision analytical model. Data on healthcare use and costs, productivity losses and health utilities were based on published and own estimates. Uncertainty was accounted for in one–way, multi–way, and probabilistic sensitivity analyses.
Results
During 2015–2019, 114,658 home care cases, 34,571 primary care cases, 7,381 severe cases, and 2 deaths associated with rotavirus disease were avoided due to vaccination. Under baseline assumptions vaccination was cost–effective from a healthcare perspective with a cost per QALY of € 47,447 for Rotarix® and € 52,709 for RotaTeq®. The break–even price was € 70 for Rotarix® and € 67 for RotaTeq®. Vaccination was cost–saving from the societal perspective, and also from a healthcare perspective for vaccine prices below € 25 and € 22 per vaccinated child for Rotarix® and RotaTeq®, respectively.
Conclusion
Ongoing childhood rotavirus vaccination in Norway has reduced the rotavirus disease burden substantially, and is cost–effective compared with no vaccination.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0183306（source: https://plos.figshare.com/articles/dataset/Re_evaluation_of_the_cost_effectiveness_and_effects_of_childhood_rotavirus_vaccination_in_Norway/5321155）。